Overview

Ability to Awaken in Nonmonosymptomatic Enuresis

Status:
Completed
Trial end date:
2015-07-01
Target enrollment:
0
Participant gender:
All
Summary
To evaluate the effect of controlling lower urinary tract symptoms (LUTS) with anticholinergics on improving the ability to awaken (AA) in children with nonmonosymptomatic enuresis and evaluate the potential implication of improved AA for treatment response prediction.
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Seoul National University Hospital
Treatments:
Cholinergic Antagonists
Criteria
Inclusion Criteria:

- primary nonmonosymptomatic enuresis who received initial anticholinergic therapy

Exclusion Criteria:

- any urological abnormalities including neuropathic bladder